1st Quarter - Report

COMPLETE PHARMA HOLDINGS LLC (CP) (FORMERLY: MARATHON PHARMACEUTICALS, LLC) for COMPLETE PHARMA HOLDINGS LLC (CP) (FORMERLY: MARATHON PHARMACEUTICALS LLC)

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 289 - The American Cures Act, provisions related to investment in research and development H.R. 6 - The 21st Century Cure Act, Provision related to investment in research and development, provision related to FDA product review. Issues Related to Duchenne Muscular Dystrophy. Issues Related to Precision Medicine in Rare Diseases Discussions related to the role of Marathon Pharmaceuticals, LLC as a rare disease company and the sale of legacy products.

LobbyistCovered position, as disclosed
GREGORY ARONIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th), S. 289 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.